Nu Skin Enterprises Reports Fourth Quarter and Full-Year 2025 Results Within Guidance

Company provides initial outlook for Q1 and fiscal year 2026, forecasting a return to revenue growth by year’s end. 

Provo, Utah — Nu Skin Enterprises Inc. (NYSE: NUS) announced fourth quarter and full-year 2025 revenue and earnings within guidance with more than 50% growth in earnings for 2025.

“We are pleased to achieve fourth quarter results within our guidance range for both revenue and earnings per share,”

said Ryan Napierski, Nu Skin president and CEO.

“This past year was a pivotal year as we furthered our transformation toward becoming the world’s leading intelligent beauty and wellness platform and laid the groundwork for our 2026 growth initiatives. Looking ahead, we continue to build sales leader alignment in the first half of the year around the global launch of Prysm iO, positioning us for a return to year-over-year revenue growth by year’s end.

“We are now placing Prysm iO intelligent wellness devices into the hands of sales leaders around the world ahead of our consumer launch in the second half of the year. More than 20,000 devices are already in the hands of our sales leaders generating more than 700,000 scans. As we gain greater adoption and more individuals are scanning and receiving their personalized product recommendations, we anticipate this will drive growth in subscriptions leading to greater customer lifetime value.

“We have also begun pre-market activities in India, setting the operational foundation and infrastructure ahead of a full market opening anticipated in the back half of the year.

“Overall, we are encouraged by the progress we are making and believe these two initiatives give us the greatest opportunity for sustainable, long-term growth and increased shareholder value.”

Executive Summary
Q4 2025 vs. Prior-Year Quarter

Revenue	$370.3 million; (16.9)% or (10.4)% excluding Mavely 2024 revenue · (0.2)% FX impact or $(0.8) million
Earnings Per Share (EPS)	$0.29 compared to $(0.73) or $0.38 excluding restructuring and other charges
Customers	748,796; (10)%
Paid Affiliates	129,311; (11)%
Sales Leaders	30,045; (19)%

Executive Summary
2025 vs. 2024

Revenue:	$1.49 billion; (14.3)% or (10.7%) excluding Mavely 2024 revenue · (0.8)% FX impact or $(13.4) million
Earnings Per Share (EPS):	$3.18 or $1.27 excluding Mavely gain and other charges compared to $(2.95) or $0.84 excluding restructuring and other charges

Q4 2025 Year-Over-Year Operating Results

Revenue	$370.3 million compared to $445.6 million or $413.3 million excluding Mavely 2024 revenue · (0.2)% FX impact or $(0.8) million
Gross Margin	70.7% compared to 62.7% or 71.4% excluding inventory write-off · Nu Skin business was 77.6% compared to 67.5% or 76.6% excluding inventory write-off
Selling Expenses	35.5% compared to 37.1% · Nu Skin business was 40.8% compared to 40.3%
G&A Expenses	29.0% compared to 27.1%
Operating Margin	6.3% compared to (11.9)% or 7.7% excluding restructuring and other charges
Interest Expense	$4.0 million compared to $5.9 million
Other Income (Expense)	$(1.1) million compared to $1.1 million
Income Tax Rate	20.3% compared to 37.5% or 36.6% excluding restructuring and other charges
EPS	$0.29 compared to $(0.73) or $0.38 excluding restructuring and other charges

Stockholder Value

Dividend Payments	$2.9 million
Stock Repurchases	$10.0 million · $142.3 million remaining in authorization

Q1 and Full-year 2026 Outlook

Q1 2026 Revenue	$320 to $340 million; (12)% to (7)% · Approximately (1)% FX impact
Q1 2026 EPS	$0.10 to $0.20
2026 Revenue	$1.35 to $1.50 billion; (9)% to 1% · Approximately (1)% FX impact
2026 EPS	$0.80 to $1.20

“We are pleased with how we performed this year, growing earnings by more than 50% due to effective margin improvement and cost optimization amidst top-line pressures,”

said James D. Thomas, Chief Financial Officer.

“As we look to return to year-over-year growth by year’s end, our annual revenue guidance is $1.35 to $1.50 billion, with an approximate 1% foreign currency headwind. We anticipate EPS of $0.80 to $1.20 with a forecasted tax rate of 35%. For the first quarter, which is typically our lowest quarter due to seasonality of our business, we project revenue of $320 to $340 million. This assumes a negative foreign currency impact of approximately 1%. We project earnings per share of $0.10 to $0.20.”

About Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

SOURCE: Nu Skin